1. Home
  2. KURA
  3. KURA News

Latest Kura Oncology Inc. (KURA) News on March 24, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KURA

GlobeNewswire

17 days ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KURA

MT Newswires

18 days ago

UBS Adjusts Price Target on Kura Oncology to $14 From $27, Keeps Buy Rating

Kura Oncology (NASDAQ:KURA) shareholders have endured a 64% loss from investing in the stock a year ago
KURA

Simply Wall St.

25 days ago

Kura Oncology (NASDAQ:KURA) shareholders have endured a 64% loss from investing in the stock a year ago

KURA

Thomson Reuters StreetEvents

25 days ago

Q4 2024 Kura Oncology Inc Earnings Call

Kura Oncology Inc (KURA) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Growth
KURA

GuruFocus.com

a month ago

Kura Oncology Inc (KURA) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Growth

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates
KURA

Zacks

a month ago

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

KURA

Associated Press Finance

a month ago

Kura Oncology: Q4 Earnings Snapshot

Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results
KURA

GlobeNewswire

a month ago

Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results

Kura Oncology to Participate in Three Upcoming Investor Conferences
KURA

GlobeNewswire

a month ago

Kura Oncology to Participate in Three Upcoming Investor Conferences

Kura Oncology to Report Fourth Quarter and Full Year 2024 Financial Results
KURA

GlobeNewswire

a month ago

Kura Oncology to Report Fourth Quarter and Full Year 2024 Financial Results

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KURA

GlobeNewswire

a month ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KURA

MT Newswires

2 months ago

Wedbush Adjusts Kura Oncology's Price Target to $26 From $34, Maintains Outperform Rating

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
KURA

GlobeNewswire

2 months ago

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

KURA

MT Newswires

3 months ago

Kura Oncology Promotes Mollie Leoni to Chief Medical Officer

Kura Oncology Announces Senior Executive Promotions
KURA

GlobeNewswire

3 months ago

Kura Oncology Announces Senior Executive Promotions

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
KURA

GlobeNewswire

4 months ago

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

Why Is Kura Oncology, Inc. (KURA) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
KURA

Insider Monkey

4 months ago

Why Is Kura Oncology, Inc. (KURA) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?

Kura Oncology to Host Virtual Investor Event on December 9, 2024
KURA

GlobeNewswire

4 months ago

Kura Oncology to Host Virtual Investor Event on December 9, 2024

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit
KURA

GlobeNewswire

4 months ago

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit

Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds
KURA

Insider Monkey

4 months ago

Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial
KURA

BioPharma Dive

4 months ago

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial

Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover
KURA

Investor's Business Daily

4 months ago

Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover

Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
KURA

Investor's Business Daily

4 months ago

Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%

KURA

MT Newswires

4 months ago

Wedbush Lowers Price Target on Kura Oncology to $34 From $37, Keeps Outperform Rating

Kura Oncology partners Kyowa Kirin to advance AML treatment
KURA

Pharmaceutical Technology

4 months ago

Kura Oncology partners Kyowa Kirin to advance AML treatment

KURA

MT Newswires

4 months ago

Kura Oncology, Kyowa Kirin to Jointly Develop of Blood Cancer Drug

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
KURA

PR Newswire

4 months ago

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

Kura Oncology Inc (KURA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising Expenses
KURA

GuruFocus.com

5 months ago

Kura Oncology Inc (KURA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising Expenses

KURA

Associated Press Finance

5 months ago

Kura Oncology: Q3 Earnings Snapshot

Kura Oncology Reports Third Quarter 2024 Financial Results
KURA

GlobeNewswire

5 months ago

Kura Oncology Reports Third Quarter 2024 Financial Results

Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting
KURA

GlobeNewswire

5 months ago

Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting

Kura Oncology to Report Third Quarter 2024 Financial Results
KURA

GlobeNewswire

5 months ago

Kura Oncology to Report Third Quarter 2024 Financial Results

KURA

MT Newswires

5 months ago

UBS Initiates Kura Oncology With Buy Rating, $27 Price Target

Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (GIST)
KURA

GlobeNewswire

5 months ago

Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (GIST)

Kura Oncology to Present New Data Supporting Combination of KO-2806 with KRAS G12C and Pan-RAS Inhibitors
KURA

GlobeNewswire

5 months ago

Kura Oncology to Present New Data Supporting Combination of KO-2806 with KRAS G12C and Pan-RAS Inhibitors

Kura Oncology Inc (KURA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs
KURA

GuruFocus.com

6 months ago

Kura Oncology Inc (KURA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs

KURA

MT Newswires

6 months ago

Kura Oncology Reports 'Encouraging' Results From Trial of Potential Leukemia Treatment

Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology
KURA

GlobeNewswire

6 months ago

Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology

Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors
KURA

GlobeNewswire

6 months ago

Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors

Kura Oncology to Participate in Cantor Global Healthcare Conference
KURA

GlobeNewswire

6 months ago

Kura Oncology to Participate in Cantor Global Healthcare Conference

Kura Oncology, Inc. (KURA): This Small-Cap Healthcare Stock Is A Good Buy Right Now
KURA

Insider Monkey

7 months ago

Kura Oncology, Inc. (KURA): This Small-Cap Healthcare Stock Is A Good Buy Right Now

KURA

Associated Press Finance

8 months ago

Kura Oncology: Q2 Earnings Snapshot

Kura Oncology Reports Second Quarter 2024 Financial Results
KURA

GlobeNewswire

8 months ago

Kura Oncology Reports Second Quarter 2024 Financial Results

KURA

MT Newswires

8 months ago

Kura Oncology Says FDA Clears Ziftomenib Clinical Study in Advanced GIST

Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST)
KURA

GlobeNewswire

8 months ago

Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST)

Kura Oncology to Report Second Quarter 2024 Financial Results
KURA

GlobeNewswire

8 months ago

Kura Oncology to Report Second Quarter 2024 Financial Results

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KURA

GlobeNewswire

9 months ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Estimating The Intrinsic Value Of Kura Oncology, Inc. (NASDAQ:KURA)
KURA

Simply Wall St.

9 months ago

Estimating The Intrinsic Value Of Kura Oncology, Inc. (NASDAQ:KURA)

Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes
KURA

GlobeNewswire

9 months ago

Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KURA

GlobeNewswire

10 months ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology to Participate in Jefferies Global Healthcare Conference
KURA

GlobeNewswire

10 months ago

Kura Oncology to Participate in Jefferies Global Healthcare Conference

KURA

MT Newswires

10 months ago

Kura Oncology Enrolls 85 Patients in Ziftomenib Trial for Leukemia Drug

Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
KURA

GlobeNewswire

10 months ago

Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML

2 Incredible Growth Stocks to Buy Hand Over Fist
KURA

Motley Fool

a year ago

2 Incredible Growth Stocks to Buy Hand Over Fist

Kura Oncology to Participate in Bank of America Securities Healthcare Conference
KURA

GlobeNewswire

a year ago

Kura Oncology to Participate in Bank of America Securities Healthcare Conference

Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript
KURA

Insider Monkey

a year ago

Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KURA

GlobeNewswire

a year ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KURA

GuruFocus.com

a year ago

Kura Oncology Inc (KURA) (Q1 2024) Earnings Call Transcript Highlights: Key Financial and ...

KURA

Associated Press Finance

a year ago

Kura Oncology: Q1 Earnings Snapshot

Kura Oncology Reports First Quarter 2024 Financial Results
KURA

GlobeNewswire

a year ago

Kura Oncology Reports First Quarter 2024 Financial Results

Kura Oncology to Report First Quarter 2024 Financial Results
KURA

GlobeNewswire

a year ago

Kura Oncology to Report First Quarter 2024 Financial Results

Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
KURA

GlobeNewswire

a year ago

Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML

Kura Oncology to Participate in Stifel Targeted Oncology Forum
KURA

GlobeNewswire

a year ago

Kura Oncology to Participate in Stifel Targeted Oncology Forum

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KURA

GlobeNewswire

a year ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma
KURA

GlobeNewswire

a year ago

Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KURA

GlobeNewswire

a year ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript
KURA

Insider Monkey

a year ago

Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript

KURA

Thomson Reuters StreetEvents

a year ago

Q4 2023 Kura Oncology Inc Earnings Call

KURA

GuruFocus.com

a year ago

Kura Oncology Inc (KURA) Reports Q4 and Full Year 2023 Financial Results

KURA

Associated Press Finance

a year ago

Kura Oncology: Q4 Earnings Snapshot

Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
KURA

GlobeNewswire

a year ago

Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results

Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia
KURA

GlobeNewswire

a year ago

Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia

Kura Oncology to Participate in Three Upcoming Investor Conferences
KURA

GlobeNewswire

a year ago

Kura Oncology to Participate in Three Upcoming Investor Conferences

Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results
KURA

GlobeNewswire

a year ago

Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KURA

GlobeNewswire

a year ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Chief Medical Officer Stephen Dale Sells Shares of Kura Oncology Inc
KURA

GuruFocus.com

a year ago

Chief Medical Officer Stephen Dale Sells Shares of Kura Oncology Inc

Big banks defeat U.S. Treasury rigging appeal
KURA

Reuters

a year ago

Big banks defeat U.S. Treasury rigging appeal

Insights Into Allegiant Travel (ALGT) Q4: Wall Street Projections for Key Metrics
KURA

Zacks

a year ago

Insights Into Allegiant Travel (ALGT) Q4: Wall Street Projections for Key Metrics

EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
KURA

GlobeNewswire

a year ago

EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Bank of America Is Upbeat, but Preparing for a Worst-Case Outcome
KURA

Motley Fool

a year ago

Bank of America Is Upbeat, but Preparing for a Worst-Case Outcome

Kura Makes Good On Its $150 Million Infusion And Shoots Up 12%
KURA

Investor's Business Daily

a year ago

Kura Makes Good On Its $150 Million Infusion And Shoots Up 12%

Safehold Sets Fourth Quarter and Fiscal Year 2023 Earnings Release and Webcast
KURA

PR Newswire

a year ago

Safehold Sets Fourth Quarter and Fiscal Year 2023 Earnings Release and Webcast

Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
KURA

GlobeNewswire

a year ago

Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia

EyePoint Pharmaceuticals Inc SVP & Chief Commercial Officer David Jones Sells 26,017 Shares
KURA

GuruFocus.com

a year ago

EyePoint Pharmaceuticals Inc SVP & Chief Commercial Officer David Jones Sells 26,017 Shares

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
KURA

CNW Group

a year ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

12 Most Promising Green Stocks According to Analysts
KURA

Insider Monkey

a year ago

12 Most Promising Green Stocks According to Analysts

Is Couchbase, Inc. (NASDAQ:BASE) Trading At A 34% Discount?
KURA

Simply Wall St.

a year ago

Is Couchbase, Inc. (NASDAQ:BASE) Trading At A 34% Discount?

Provident Financial Services, Inc. (NYSE:PFS) Q4 2023 Earnings Call Transcript
KURA

Insider Monkey

a year ago

Provident Financial Services, Inc. (NYSE:PFS) Q4 2023 Earnings Call Transcript

Array Technologies, Inc. (ARRY) Falls More Steeply Than Broader Market: What Investors Need to Know
KURA

Zacks

a year ago

Array Technologies, Inc. (ARRY) Falls More Steeply Than Broader Market: What Investors Need to Know

Exclusive-Morgan Stanley plans to double private credit portfolio to $50 billion
KURA

Reuters

a year ago

Exclusive-Morgan Stanley plans to double private credit portfolio to $50 billion

Homebuilding Market Likely to Witness a Rebound in 2024
KURA

Zacks

a year ago

Homebuilding Market Likely to Witness a Rebound in 2024

EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 16,386 Shares
KURA

GuruFocus.com

a year ago

EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 16,386 Shares

Virtu Financial Inc (VIRT) Reports Mixed Fourth Quarter and Full Year 2023 Results
KURA

GuruFocus.com

a year ago

Virtu Financial Inc (VIRT) Reports Mixed Fourth Quarter and Full Year 2023 Results

Virtu Financial (VIRT) Lags Q4 Earnings and Revenue Estimates
KURA

Zacks

a year ago

Virtu Financial (VIRT) Lags Q4 Earnings and Revenue Estimates

Is There An Opportunity With Kura Oncology, Inc.'s (NASDAQ:KURA) 42% Undervaluation?
KURA

Simply Wall St.

a year ago

Is There An Opportunity With Kura Oncology, Inc.'s (NASDAQ:KURA) 42% Undervaluation?

KURA

Associated Press Finance

a year ago

Virtu Financial: Q4 Earnings Snapshot

Kura Oncology Rockets 46% Before Unveiling Cancer Drug Test Results — Here's Why
KURA

Investor's Business Daily

a year ago

Kura Oncology Rockets 46% Before Unveiling Cancer Drug Test Results — Here's Why

Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?
KURA

Benzinga

a year ago

Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?

Kura Oncology Announces Oversubscribed $150 Million Private Placement
KURA

GlobeNewswire

a year ago

Kura Oncology Announces Oversubscribed $150 Million Private Placement

Global Partners LP (GLP) Outperforms Broader Market: What You Need to Know
KURA

Zacks

a year ago

Global Partners LP (GLP) Outperforms Broader Market: What You Need to Know

Share on Social Networks: